Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-07-24Clinical Trial Update: Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC [Phase 2]
A Phase 2 trial evaluating cabazitaxel for brain metastases arising from breast cancer and non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2014-07-24Clinical Trial Update: Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy [Phase 2]
A Phase 2 clinical trial is evaluating how indocyanine green distributes within breast tumors and axillary lymph nodes after neoadjuvant the…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors [Phase 2]
Phase 2 trial evaluated omega-3 fatty acid for joint symptoms in breast cancer patients treated with aromatase inhibitors; the study was ter…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Domiciliary Physiotherapy During Breast Cancer Radiation [NA]
A completed clinical trial evaluated domiciliary physiotherapy during breast cancer radiation and its effect on shoulder pain. The study was…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer [NA]
This completed clinical trial evaluates nipple aspiration, ductal lavage, and duct endoscopy as screening methods for women at moderate-to-h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-07-23Clinical Trial Update: Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients [NA]
Clinical trial update describes a study on the effectiveness and efficiency of physical exercise in cancer patients, with conditions includi…
-
FDA approval · 2014-07-22FDA Approved: XELODA — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for XELODA (capecitabine) from H2-Pharma, LLC. This notice confirms regulatory approval of a cha…
-
CLINICAL_TRIALS research · 2014-07-22Clinical Trial Update: Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer [Phase 4]
This Phase 4 clinical trial update examines weekly versus every-three-week administration of paclitaxel liposome injection for metastatic br…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer [Phase 2]
This is a Phase 2 trial update reporting results for combining lapatinib with paclitaxel as first-line therapy for ErbB2/amplified metastati…
-
CLINICAL_TRIALS research · 2014-07-21Clinical Trial Update: Non Invasive Detection of Lung and Breast Cancer by Odor Signature
The document provides a clinical trial update on a non-invasive test that detects lung and breast cancer by an odor signature, sponsored by …
-
FDA approval · 2014-07-19FDA Approved: LETROZOLE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's generic letrozole, confirming regulatory approval of the generic aromatase i…
-
FDA approval · 2014-07-18FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approves a supplemental application for VABRINTY (leuprolide acetate) submitted by Uronova Pharmaceuticals, Inc. The approval updates th…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects. [Phase 2]
A Phase 2 trial evaluating electrochemotherapy for chest wall recurrence of breast cancer was terminated, with results posted in 2014 discus…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: First Line Therapy for Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial update for first-line therapy in metastatic breast cancer has terminated; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) [Phase 3]
Phase 3 study comparing ETC versus EC-TX regimens and Ibandronate versus observation in node-positive primary breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Study in Elderly Patients With Early Breast Cancer (ICE) [Phase 3]
A Phase 3 clinical trial in elderly patients with early breast cancer (ICE) has completed recruitment and status is reported as completed.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer [Phase 2]
A Phase 2 trial comparing anastrozole plus placebo to anastrozole plus gefitinib (ZD1839) in postmenopausal patients with ER/PR-positive met…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and nab-paclitaxel with or without vorinostat in newly diagnosed operable breast cancer; results were p…
-
CLINICAL_TRIALS research · 2014-07-16Clinical Trial Update: Spectroscopy of Breast Tissue
This entry reports on a completed clinical trial examining spectroscopic analysis of breast tissue in breast cancer. The sponsor is Case Com…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer [Phase 2]
A Phase 2 clinical trial assessed the safety and leukostimulatory activity of Panagen in patients with breast cancer; results have been post…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer
Update on a clinical trial evaluating gemcitabine as a single-agent maintenance chemotherapy for patients with metastatic breast cancer.
-
FDA approval · 2014-07-11FDA Approved: KADCYLA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for KADCYLA (ado-trastuzumab emtansine) submitted by Genentech, Inc.
-
CLINICAL_TRIALS research · 2014-07-11Clinical Trial Update: Ambulatory SNP Under Local Anaesthesia in a Subgroup of Breast Cancer Patients - Trial [NA]
A clinical trial update describes ambulatory SNP under local anesthesia in a subgroup of patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy. [Phase 1, Phase 2]
This update reports the completion of a Phase 1/Phase 2 clinical trial evaluating an exercise intervention for patients with early-stage bre…
-
FDA approval · 2014-07-10FDA Approved: DOCETAXEL — Supplemental Application (Hospira, Inc.)
FDA approved Hospira, Inc.'s supplemental application for Docetaxel.